Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Unspecified Adult Solid Tumor × TIC10 compound × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor 1 Solid Tumors 1 Obesity 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Disease 1 Diffuse Intrinsic Pontine Glioma 1 Carcinosarcoma 1

Interventions

TIC10 compound 1 Sorafenib 1 Pemetrexed 1 Imatinib Mesylate 1 Cyclophosphamide 1 Biopsy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02324621 2019-05-22

Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors

Rutgers, The State University of New Jersey

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡